Henry James International Management Inc. Nu Cana PLC Transaction History

Henry James International Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 30, 2021	SELL	$2.7 - $5.04 $191,824 - $358,071	-71,046 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$4.38 - $7.0 $311,181 - $497,322	71,046 New	71,046 $355,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $68.4M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Henry James International Management Inc., based on Form 13F filings with the SEC.

Stay updated on Henry James International Management Inc. with notifications on news.